Does the evidence actually show that microbiome diversity reduces inflammation?
Yes, but the strongest proof comes from studies that directly changed the microbiome and measured inflammation. In a 2022 randomized controlled trial, 34 chronic kidney disease patients received either a synbiotic (three bacterial strains plus inulin fiber) or a placebo for 12 weeks [1]. The treatment group saw a 39.5% drop in high-sensitivity C-reactive protein (hs-CRP), a key marker of systemic inflammation, while the placebo group dropped only 8.5% [1]. This is a direct cause-and-effect demonstration: change the microbiome, lower inflammation.
A much larger 2021 study of 1,425 people—including healthy individuals and those with Crohn's disease, ulcerative colitis, or irritable bowel syndrome—found that long-term dietary patterns were consistently linked to pro- or anti-inflammatory gut ecosystems [4]. Plant foods and fish were associated with higher levels of short-chain fatty acid-producing bacteria, which are known to calm inflammation. Processed and animal-derived foods were linked to bacteria that produce endotoxins, which trigger inflammation [4]. This doesn't prove causation, but the consistency across four different cohorts strengthens the case.
For whom does this work best? The answer depends on your health condition.
The benefits are clearest in people with existing chronic inflammatory conditions. The 2022 synbiotic trial was done in chronic kidney disease patients, who typically have high inflammation and a disrupted gut microbiome [1]. The 39.5% reduction in hs-CRP is a large effect, but it came from a group that started with elevated inflammation. Similarly, a 2022 review on obesity noted that obesity is characterized by both reduced microbial diversity and chronic low-grade inflammation, and that manipulating the microbiome (via probiotics, prebiotics, or fecal transplants) holds promise for reducing that inflammation [2].
However, for healthy people without chronic inflammation, the evidence is less direct. The 2021 diet-microbiome study included healthy controls and found that their microbiomes still responded to diet—plant-based eaters had more anti-inflammatory bacteria [4]. But the study didn't measure inflammation levels directly in healthy people, so we can't say how much a healthy person's inflammation would drop. The 2023 study on inflammatory bowel disease (IBD) showed that even in remission, Crohn's disease patients had persistently altered gut bacteria and brain changes linked to chronic inflammation [3]. This suggests that once inflammation is established, restoring microbiome diversity may be harder and take longer.
What can you actually do to increase microbiome diversity and reduce inflammation?
The evidence points to two practical strategies: eat more plant-based and fish-rich foods, and consider a synbiotic supplement if you have a chronic condition. The 2021 study identified specific foods linked to anti-inflammatory bacteria: vegetables, fruits, legumes, whole grains, and fish [4]. These foods feed bacteria that produce short-chain fatty acids, which directly calm immune responses in the gut. Processed meats, high-fat dairy, and sugary drinks were linked to pro-inflammatory bacteria [4].
For people with existing disease, a synbiotic—a combination of probiotics (live beneficial bacteria) and prebiotics (fiber that feeds them)—can work. The 2022 trial used 32 billion colony-forming units per day of Lactobacillus and Bifidobacterium strains plus 3.2 grams of inulin [1]. This is a high dose, and it was safe (only two patients reported increased gas). But it's not a substitute for diet: the 2021 study showed that long-term dietary patterns, not short-term supplements, had the strongest associations with microbiome composition [4]. So the most evidence-backed approach is to change your diet first, then consider a synbiotic if you have a diagnosed inflammatory condition.
About These Sources
This answer is built on 5 peer-reviewed studies — published from 2021 to 2024, 1 from 2024 or later, 4 in Q1 journals, collectively cited 808 times — selected as the most relevant from 5 studies that passed quality screening, drawn from 54 papers retrieved from a database of over 500 million.
Sources used in this answer
The Impact of Synbiotic Treatment on the Levels of Gut-Derived Uremic Toxins, Inflammation, and Gut Microbiome of Chronic Kidney Disease Patients—A Randomized Trial
In a 12-week randomized controlled trial of 34 chronic kidney disease patients, a synbiotic (probiotics plus inulin) increased beneficial bacteria and reduced the inflammatory marker hs-CRP by 39.5% (vs. 8.5% in placebo), while also improving kidney function.
The critical role of gut microbiota in obesity
A 2022 review of obesity research concluded that obesity is linked to reduced gut microbial diversity and increased Firmicutes/Bacteroidetes ratio, and that altered microbiota contribute to chronic inflammation—making microbiome manipulation a promising therapy.
Brain signatures of chronic gut inflammation
A 2023 study of 70 people with inflammatory bowel disease found that Crohn's disease patients had persistently altered gut bacteria even in remission, and this was linked to changes in brain networks involved in interoception and anxiety.
Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome
In a 2021 meta-analysis of 1,425 individuals (healthy and with IBD/IBS), plant-based and fish-rich diets were consistently associated with anti-inflammatory bacteria and short-chain fatty acid pathways, while processed and animal-derived foods were linked to pro-inflammatory endotoxin pathways.
The gut microbiota in thrombosis
A 2024 review on thrombosis and the gut microbiota reported that impaired gut barrier function and microbial metabolites promote low-grade inflammation and thrombus formation, identifying the gut microbiome as a risk factor for cardiovascular disease.